US equities
|
MU
$953.19
▲+0.00%
SNDK
$1,482.33
▲+0.00%
ASML
$1,717.76
▲+0.00%
NVDA
$228.52
▲+0.00%
SPCX
$156.54
▲+0.00%
AMD
$605.53
▲+0.00%
SKHY
$157.06
▲+0.00%
INTC
$102.81
▲+0.00%
MU
$953.19
▲+0.00%
SNDK
$1,482.33
▲+0.00%
ASML
$1,717.76
▲+0.00%
NVDA
$228.52
▲+0.00%
SPCX
$156.54
▲+0.00%
AMD
$605.53
▲+0.00%
SKHY
$157.06
▲+0.00%
INTC
$102.81
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Apyx Medical Corporation - Common Stock
(NQ:
APYX
)
2.600
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Apyx Medical Corporation - Common Stock
< Previous
1
2
3
4
Next >
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures
August 08, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook
August 08, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
July 25, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
May 09, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corp. (NASDAQ: APYX) Leading the Way in Friday Trading Based on Percentage Gain
May 12, 2023
Via
Investor Brand Network
Apyx Medical Corporation Announces Board Leadership Transition
May 09, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
April 25, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
April 11, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
March 21, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
March 04, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
February 21, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
January 22, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
January 08, 2024
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
November 28, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors
November 09, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
November 09, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November
November 07, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
October 02, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook
August 10, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023
June 29, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece
June 14, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
May 11, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring
April 28, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
April 05, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook
March 16, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed
February 27, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial
February 21, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023
February 16, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction
February 01, 2023
From
Apyx Medical Corporation
Via
Business Wire
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results
January 10, 2023
From
Apyx Medical Corporation
Via
Business Wire
< Previous
1
2
3
4
Next >
